A novel treatment strategy using indocyanine green for transarterial chemoembolization in BCLC stage C hepatocellular carcinoma

ConclusionsThe SBI is suitable and may provide survival benefits for TACE treatments in BCLC stage C HCC patients.

Source: Cancer Medicine - November 7, 2019 Category: Cancer & Oncology Authors: Jie Mei, Shao ‐Hua Li, Qiao‐Xuan Wang, Xiao‐Ping Zhong, Liang‐He Lu, Anna Kan, Wei Wei, Rong‐Ping Guo Tags: ORIGINAL RESEARCH Source Type: research